MedPath

Using Isosorbide Mononitrate in Reducing Time in Induction of Labor in Post Date Women

Phase 2
Conditions
Induction of Labor
Interventions
Registration Number
NCT03854383
Lead Sponsor
Abdelrahman Ali Fadel Youssef Mohamed
Brief Summary

We will compare between using isosorbide mononitrate together with misoprostol versus the misoprostol alone in induction of labor in postdate women

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • age (20-35 yrs)
  • single fetus
  • gestational age > 40weeks
  • not in labor
  • bishop score < 7
  • no medical disorder
Exclusion Criteria
  • Gestational age ≤40 weeks
  • patient with a ripe cervix
  • rupture of membranes
  • suspected chorioamnionitis
  • placenta previa
  • history of major uterine surgery
  • hypertonic uterine pattern
  • contraindicated to receive PG
  • fetal malpresentation
  • multiple pregnancy
  • intrauterine growth retardation
  • women with any general medical disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Misoprostol aloneMisoprostolEnrolled women will receive 25 πg of misoprostol which will be placed intravaginally 4 hourly, maximum up to 5 doses
Isosorbide mononitrate with misoprostolIsosorbide mononitrateEnrolled women will receive 25 πg of misoprostol together with 40 mg isosorbide mononitrate which will be placed intravaginally 4 hourly, maximum up to 5 doses
Isosorbide mononitrate with misoprostolMisoprostolEnrolled women will receive 25 πg of misoprostol together with 40 mg isosorbide mononitrate which will be placed intravaginally 4 hourly, maximum up to 5 doses
Primary Outcome Measures
NameTimeMethod
The duration of induction to active phase interval12 weeks

Measure the time between the beginning of the induction to enter the active phase of labor

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ain Shams maternity hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath